The Italian Biotech Start-up founded by San Raffaele Hospital, Pierluigi Paracchi, Luigi Naldini and Bernhard Gentner, raised Euro 6.2 million (USD 7.2 million) with the support of Banca Esperia. And aims to close the Series A round at Euro 10 million (USD 11.6 million).